Stock 241 ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Alibaba Health Information Technology Limited

Equities

241

BMG0171K1018

Drug Retailers

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:16 2024-04-24 am EDT 		5-day change 1st Jan Change
2.75 HKD +2.23% Intraday chart for Alibaba Health Information Technology Limited +4.96% -35.14%
Apr. 03 Alibaba Health Refutes Rumors of Purchase of Telemedicine Platform HaoDF MT
Mar. 28 Alibaba Health Information Technology Limited and Alibaba.com Enter Shared Services Agreement CI

Business Summary

Alibaba Health Information Technology Limited is specialized in the direct sale of pharmaceuticals. The turnover is divided across the following activities:

- direct sale of pharmaceuticals (85.2%);

- online sale of pharmaceuticals(12.7%);

- direct healthcare services (1.8%);

- online healthcare services and monitoring of pharmaceuticals (0.3%).

The turnover is divided into the revenue sources of product sales (80.8%) and services (19.2%).

The geographical breakdown of the turnover is as follows: mainland China (95.8%) and Hong Kong (4.2%).

Number of employees: 1,547

Sales per Business

HKD in Million2022Weight2023Weight Delta
Pharmaceutical Direct Sales
88.1 %
21,727 87.0 % 26,973 88.1 % +24.14%
Pharmaceutical E-commerce Platform
8.4 %
2,422 9.7 % 2,559 8.4 % +5.66%
Healthcare and Digital Services
3.5 %
813 3.3 % 1,067 3.5 % +31.28%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
95.0 %
24,397 97.7 % 29,069 95.0 % +19.15%
International
5.0 %
-- 1,530 5.0 % -

Managers

Managers TitleAgeSince
Di Fan Shen CEO
 Chief Executive Officer 46 -
Yan Wu Tu DFI
 Director of Finance/CFO 46 19-08-31
Shun Yan Zhu CHM
 Chairman 53 20-03-15
Hiu Leong Tsui SEC
 Corporate Secretary - 23-08-11
Yan Deng SEC
 Corporate Secretary - 23-08-11

Members of the board

Members of the board TitleAgeSince
Yi Hong Wu BRD
 Director/Board Member 56 23-08-10
Shun Yan Zhu CHM
 Chairman 53 20-03-15
Rong Shao BRD
 Director/Board Member 62 23-08-10
Yi Fei Huang BRD
 Director/Board Member 51 19-06-08
Di Fan Shen CEO
 Chief Executive Officer 46 -
Yan Wu Tu DFI
 Director of Finance/CFO 46 19-08-31
Jiaojiao Huang BRD
 Director/Board Member 42 23-05-14
Haipeng Xu BRD
 Director/Board Member 38 23-10-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 13,540,212,542 5,039,510,037 ( 37.22 %) 6,713,000 ( 0.0496 %) 37.22 %

Shareholders

NameEquities%Valuation
ALIBABA GROUP HOLDING LIMITED
63.83 %
10,271,540,755 63.83 % 4 173 M $
Xiao Ying Chen
4.832 %
777,484,030 4.832 % 316 M $
China Asset Management Co., Ltd.
0.4473 %
71,978,000 0.4473 % 29 M $
Fullgoal Fund Management Co., Ltd.
0.3810 %
61,314,000 0.3810 % 25 M $
Bosera Asset Management Co., Ltd.
0.2804 %
45,122,000 0.2804 % 18 M $
Bank of Communications Schroder Fund Management Co., Ltd.
0.2528 %
40,674,000 0.2528 % 17 M $
UBS Asset Management (Hong Kong) Ltd.
0.1928 %
31,018,000 0.1928 % 13 M $
Tian Hong Asset Management Co., Ltd.
0.1134 %
18,254,000 0.1134 % 7 M $
Orient Securities Asset Management Co. Ltd.
0.0905 %
14,562,000 0.0905 % 6 M $
State Street Global Advisors Ltd.
0.0891 %
14,345,711 0.0891 % 6 M $

Holdings

NameEquities%Valuation
SHUYU CIVILIAN PHARMACY CORP., LTD.
31.18%
 34,080,000 31.18% 62,666,986 $
ANHUI HUAREN HEALTH PHARMACEUTICAL CO., LTD.
8.74%
 30,049,373 8.74% 49,767,471 $

Company contact information

Alibaba Health Information Technology Ltd.

26/F, Tower One Times Square, 1 Matheson Street

, Hong Kong

+

address Alibaba Health Information Technology Limited(241)

Sector

Consumer Non-Cyclicals
Food & Drug Retailing
Food & Drug Retailing
Drug Retailers
Other Drug Retailers

Sales per Business

Sales per region

Ratings for Alibaba Health Information Technology Limited

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
2.487 CNY
Average target price
5.072 CNY
Spread / Average Target
+103.92%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-35.14% 5.52B
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-30.89% 15.57B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-36.19% 9.81B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-10.45% 6.03B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+8.92% 6.08B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
0.00% 4.75B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+52.93% 4.23B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-12.02% 3.6B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-19.68% 3.14B
WELCIA HOLDINGS CO., LTD. Stock Welcia Holdings Co., Ltd.
-5.68% 3.16B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. 241 Stock
  4. Company Alibaba Health Information Technology Limited